Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasma kallikrein (Homo sapiens (Human)) | BDBM283443 (US10023557, Example 95 | US10266515, Example 95 | ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283445 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-ch...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283447 (6-((4-(((6-amino-2,4-dimethylpyridin-3- yl)methyl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283448 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283449 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3,8-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283450 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283451 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((3-ch...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283452 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283549 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283454 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283456 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283458 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283459 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283460 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((2-me...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283461 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283462 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283463 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- methylq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283464 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283465 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-me...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283466 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((6- fluoroq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283467 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283468 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283469 (N-((6-amino-2-methylpyridin-3-yl)methyl)-2- ((6-fl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283470 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283471 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283472 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- fluoroq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283473 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- (qu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283474 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283475 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- methylq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283476 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283478 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM500277 (N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283480 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyli...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283481 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283484 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((4- cyanoqu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM378009 (N-((6-amino-2,4-dimethylpyridin-3- yl)methyl)-2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283487 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((7- chloroq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283488 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283489 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283490 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methylq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283491 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283492 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283493 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283351 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((2- cyanoqu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283353 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283354 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- cyanoqu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283355 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283360 (N-((3-chloro-6-fluoro-1H-indol-5-yl)methyl)-2- ((6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283363 (N-((6-amino-2,4-dimethylpyridin-3-yl)methyl)- 2-((...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM283364 (N-((1-aminoisoquinolin-6-yl)methyl)-2-((3- methyl-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
ATTUNE PHARMACEUTICALS, INC. US Patent | Assay Description A 10 mM solution of the test compound was made in DMSO. This solution was serially diluted 1:5 in DMSO to yield 2000, 400, 80, 16, 3.2, 0.64, 0.128, ... | US Patent US11021463 (2021) BindingDB Entry DOI: 10.7270/Q21R6TN7 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 202 total ) | Next | Last >> |